Viewing Study NCT05394792


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2026-02-01 @ 5:16 PM
Study NCT ID: NCT05394792
Status: COMPLETED
Last Update Posted: 2025-08-19
First Post: 2022-05-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic Dermatitis (AD) View
None Upadacitinib View
None RINVOQ View